References
- Daras O., Cantril R. C., Gillman M. A. 3(H)-Naloxone displacement: evidence for nitrous oxide as an opioid receptor agonist. European Journal of Pharmacology 1983; 89: 177–178
- Gillman M. A. Analgesic (subanesthctic) nitrous oxide interacts with the endogenous opioid system: a review of the evidence. Life Sciences 1986; 39: 1209–1221
- Gillman M. A., Lichtigfeld F. J. Naloxone analgesia: an update. International Journal of Neuroscicnee 1989; 48: 321–324
- Gillman M. A., Kok L., Lichtigfeld E. J. Paradoxical effect of naloxone on nitrous oxide analgesia in man. European Journal of Pharmacology 1980; 61: 175–177
- Levine J. D., Gordon N. C., Taiwo Y. O., Coderre T. J. Potentiation of pentazocine analgesia by low-dose naloxone. Journal of Clinical Investigation 1988; 82: 1574–1577
- Millan M. J., Czlonkowski A., Lipkowski A., Herz A. Kappa-opioid-receptor-mediated antinociception in the rat II. Supraspinal in addition to spinal sites of action. The Journal of Pharmacology & Experimental Therapeutics 1989; 251: 342–350
- Mucha R., Herz A. Motivational properties of kappa and mu opioid recptor agonists studied with place and taste preference conditioning procedures. Psychopharmacology 1985; 86: 274–280
- Panerai A. E., Martini A., Sacerdote P., Mantegazza P. K-Receptor antagonist reverse “Nonopioid” stress-induced analgesia. Brain Research 1984; 304: 153–156
- Parbrook G. D. Post-operative pain relief: comparison of methadone and morphine when used concurently with nitrous oxide analgesia. British Medical Journal 1966; 2: 616–618
- Patterson S. J., Robson L. E., Kosterlitz H. W. Classification of opioid receptors. British Medical Bulletin 1983; 39: 31–36
- Sacerdote P., Mantegazza P., Panerai A. E. Analgesic effects of mu-antagonists afer naloxone non-reversible stress-induced analgesia. Brain Research 1985; 359: 34–38
- Taiwo Y. O., Basbaum A. I., Perry F., Levine J. D. Abstracts, Society for Neuroscience. 1988; volume 14: 324, (part 1) no. 134.5
- Taiwo Y. O., Basbaum A. I., Perry F., Levine J. D. Paradoxical analgesia produced by low doses of the opiate antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor. The Journal of Pharmacology & Experimental Therapeutics 1989; 249: 97–100